PHIO

#4756
Phio Pharmaceuticals Corp. Common Stock
1.2900 USD
+4.03%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
1.2600
1.3000
Faixa anual
0.9780
1.3500
Mudança diária
+4.03%
Mudança mensal
+6.61%
Mudança em 6 meses
+8.40%
Mudança anual
+8.40%
Fechamento anterior
1.2400
Abrir
1.2600
Bid
Ask
Mínimo
1.2600
High
1.3000
Volume
42
Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 14.9863 M
  • Employee 6
  • Founded 2011
  • CEO N/A
  • Website www.phiopharma.com
  • Headquarter Delaware, United States
  • FIGI BBG0024FKD97
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.72
Price to sales ratio
—

Phio Pharmaceuticals Corp

Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018.

Notícias